| Structure |
Chemical Name |
CAS |
MF |
 |
Acetyl coenzyme A sodium salt |
102029-73-2 |
C23H38N7O17P3S.3Na |
 |
TUFTSIN |
9063-57-4 |
C21H40N8O6 |
 |
Rezvilutamide |
1572045-62-5 |
C22H20F3N3O4S |
 |
Eliapixant |
1948229-21-7 |
C22H21F3N4O3S |
 |
3-Methoxysalicylaldehyde |
|
C8H8O3 |
 |
Extractant P-507 |
|
|
 |
Lerisetron |
143257-98-1 |
C18H20N4 |
 |
RNasin Inhibitor (Ribonuclease Inhibitor)) |
|
|
 |
BMS 188107 |
139232-80-7 |
C25H26N2O4 |
 |
Gelatin coating solution (1 mg/mL) |
|
|
![4-[2-PHENYL-5,7-BIS(TRIFLUOROMETHYL)PYRAZOLO[1,5-A]PYRIMIDIN-3-YL]PHENOL](/CAS/GIF/805239-56-9.gif) |
4-[2-PHENYL-5,7-BIS(TRIFLUOROMETHYL)PYRAZOLO[1,5-A]PYRIMIDIN-3-YL]PHENOL |
805239-56-9 |
C20H11F6N3O |
 |
ICG-001 |
847591-62-2 |
C33H32N4O4 |
 |
Exatecan mesylate |
169869-90-3 |
C25H26FN3O7S |
![Urea, N-[2-[2-(1,1-diMethylethyl)phenoxy]-3-pyridinyl]-N'-[4-(trifluoroMethoxy)phenyl]-](/CAS/20150408/GIF/870544-59-5.gif) |
Urea, N-[2-[2-(1,1-diMethylethyl)phenoxy]-3-pyridinyl]-N'-[4-(trifluoroMethoxy)phenyl]- |
870544-59-5 |
C23H22F3N3O3 |
 |
Ubrogepant |
1374248-77-7 |
C29H26F3N5O3 |
 |
Penicillin-Streptomycin-Gentamicin Solution,100× |
|
|
 |
AH 7614 |
6326-06-3 |
C20H17NO3S |
 |
CU-CPT-8m |
125079-83-6 |
C14H12N4O |
 |
Disodium 5'-dGMP |
33430-61-4 |
C10H15N5NaO7P |
 |
ZOTAROLIMUS (MTOR inhibitor) |
|
|
 |
SRT 2104 (SIRT1 activator) |
|
|
 |
SPERMIDINE (NNOS inhibitor) |
|
|
 |
ROSCOVITINE (SELICICLIB, CYC202) (CDK2 inhibitor) |
|
|
 |
PURMORPHAMINE (HEDGEHOG/SMOOTHENED agonist) |
|
|
 |
PONATINIB (SRC-ABL inhibitor) |
|
|
 |
OBATOCLAX MESYLATE (BCL-2 inhibitor) |
|
|
 |
LEDIPASVIR (HCV PROTEASE INHIBITOR) |
|
|
 |
FIPI (PLD1/2 inhibitor) |
|
|
 |
ENMD-2076 (FLT3 inhibitor) |
|
|
 |
DALCETRAPIB (CETP inhibitor) |
|
|
 |
CH5183284 (FGFR inhibitor) |
|
|
 |
CAL-101 (PI3K inhibitor) |
|
|
 |
BREXPIPRAZOLE (DOPAMINE RECEPTOR agonist) |
|
|
 |
BLU-9931 (FGFR inhibitor) |
|
|
 |
BEDAQUILINE (anti-tuberculosis mycobacteria) |
|
|
 |
AR-A014418 (GSK-3 inhibitor) |
|
|
 |
AM251 (CANNABINOID RECEPTOR antagonist) |
|
|
 |
SB 200646 HYDROCHLORIDE |
143797-62-0 |
C15H14N4O.ClH |
 |
RIPA BUFFER |
|
|
 |
Syphilis toluidine red non-heated serum test diagnostic reagent |
|
|
 |
BN201 |
1361200-34-1 |
C25H38FN5O4 |
 |
Rapid Blocking Buer (TBS-T) |
|
|
 |
CVN417 |
2919851-73-1 |
|
 |
GSK-CXCR2 |
211096-49-0 |
C14H9BrN6O |
 |
Protein protectant TY |
|
|
 |
Tedalinab |
916591-01-0 |
C19H21F2N3O |
 |
DL2000 DNA Marker |
|
|
 |
Ramucirumab |
947687-13-0 |
|
 |
Finerenone |
1050477-31-0 |
C21H22N4O3 |
 |
SHA 68 |
847553-89-3 |
C26H24FN3O3 |
 |
Lotilaner |
1369852-71-0 |
C20H14Cl3F6N3O3S |
 |
BIOTIN-NHS |
35013-72-0 |
C14H19N3O5S |
 |
2,5-DIFLUOROBENZENESULFONYL CHLORIDE |
26120-86-5 |
C6H3ClF2O2S |
 |
YM155 (SURVIVIN inhibitor) |
|
|
 |
VELIPARIB (ABT-888) (PARP1 inhibitor) |
|
|
 |
TIVOZANIB (VEGFR inhibitor) |
|
|
 |
TG101209 (JAK inhibitor) |
|
|
 |
SRT 1720 (SIRT1 activator) |
|
|
 |
SEMAGACESTAT (GAMMA - SECRETASE Inhibitor) |
|
|
 |
RIMONABANT (CANNABINOID RECEPTOR antagonist) |
|
|
 |
PFI-1 (BET inhibitor) |
|
|
 |
LEE011 (CDK inhibitor) |
|
|
 |
ISRIB (PERK inhibitor) |
|
|
 |
INH1 (MICROTUBULE ASSOCIATED inhibitor) |
|
|
 |
I-BET-762 (GSK525762) (BET inhibitor) |
|
|
 |
FK-506 (MTOR inhibitor) |
|
|
 |
DBEQ (P97 inhibitor) |
|
|
 |
D-LUCIFERIN POTASSIUM SALT (D-luciferin potassium salt) |
|
|
 |
AZD4547 (FGFR inhibitor) |
|
|
 |
AC480 (BMS-599626) (HER1 inhibitor) |
|
|
 |
TRPM8 Antagonist |
259674-19-6 |
C26H26N2O2 |
 |
AB 928 |
2239273-34-6 |
C23H22N8O |
 |
Active Motif |
|
|
 |
Sodium copper chlorophyllin |
28302-36-5 |
C34H29CuN4NaO7(-2) |
 |
BQ-788 |
156161-89-6 |
C34H52N5NaO7 |
 |
1-NAPHTHYLACETYL SPERMINE TRIHYDROCHLORIDE |
1049731-36-3 |
C22H35ClN4O |
 |
PBS |
|
O4P-3 |
 |
Amphotericin B solution (250 g/mL) |
|
|
 |
2-ACETAMIDO-6-CHLOROPURINE |
7602-01-9 |
C7H6ClN5O |
 |
2-ADAMANTANECARBONYL-ARG-PHE-NH2 TRIFLUOROACETATE |
876310-60-0 |
C26H38N6O3 |
![[oxido-(2,3,4,5,6-pentaphosphonatooxycyclohexyl)oxyphosphoryl] phosphate](/) |
[oxido-(2,3,4,5,6-pentaphosphonatooxycyclohexyl)oxyphosphoryl] phosphate |
193743-89-4 |
|
 |
Solifenacin |
242478-37-1 |
C23H26N2O2 |
 |
EG-011 |
2377113-41-0 |
C28H26N4O4 |
 |
ICI 216,140 |
124001-41-8 |
C45H65N13O8 |
 |
(1E,4E)-1,5-Bis(2-Methoxyphenyl)penta-1,4-dien-3-one |
39777-61-2 |
C19H18O3 |
 |
Modified telltale's solution |
|
|
 |
Platelet dilution (counting solution) |
|
|
 |
Nexopamil (racemate) |
116759-35-4 |
C24H40N2O3 |
 |
WS3 (IΚB/IKK inhibitor) |
|
|
 |
POLY-D-LYSINE/polylysine |
|
|
 |
PND-1186 (FAK inhibitor) |
|
|
 |
PI-103 (PI3K inhibitor) |
|
|
 |
PFI-4 (EPIGENETIC READER DOMAIN inhibitor) |
|
|
 |
PANOBINOSTAT (LBH589) (HDAC inhibitor) |
|
|
 |
OSELTAMIVIR ACID (NEURAMINIDASE Inhibitor) |
|
|
 |
NU-7441 (DNA-PK inhibitor) |
|
|
 |
MG-132 (PROTEASOME Inhibitor) |
|
|
 |
MASITINIB (C-KIT inhibitor) |
|
|
 |
IXAZEOMIB (MLN2238) (20S PROTEASOME Inhibitor) |
|
|
 |
ICOTINIB HCL (EGFR inhibitor) |
|
|